Articles From: Amicus Therapeutics Announces Second Quarter 2014 Financial Results and Corporate Updates to OPKO Submits IND for Rayaldee™ as Adjunctive Cancer Therapy


Results From Second Phase 3 Fabry Monotherapy Study (Study 012) on Track for 3Q14 CRANBURY, N.J., Aug.
Sign-up for Amicus Therapeutics Announces Second Quarter 2014 Financial Results and Corporate Updates investment picks
Linamar's Exceptional Performance Continues with Record Results, Strong Margins, and Continued Cash Generation Canada NewsWire GUELPH, ON , Aug.
Sign-up for Linamar's Exceptional Performance Continues with Record Results, Strong Margins, and Continued Cash Generation investment picks
WOODCLIFF LAKE, N.J., Aug.
Sign-up for I.D. Systems Reports 2014 Second Quarter and Six Months Results investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0961605001&sourceType=1 http://www.ccnmatthews.com/logos/20110512-pki_200a.jpg RED DEER, ALBERTA --
Sign-up for Parkland Fuel Corporation Reports Adjusted EBITDA of $36 Million for the Second Quarter of 2014 and Reconfirms Guidance for 2014 investment picks
2014/8/7
The Financial Select Sector SPDR® Fund (NYSE: XLF - News ), announced today that the Fund received payment as an authorized claimant from a class action settlement related to Citigroup, Inc. The total amount payable to the Fund is listed below.
Sign-up for SPDR® ETF Family Announces Impact of Receiving Settlement Payment investment picks
Oxygen Biotherapeutics, Inc. (NASDAQ: OXBT), a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, announced today that John Kelley, Chief Executive Officer, will present a company overview at the Wedbush 2014 Life Sciences Management Access Conference at Le Parker Meridien in New York on Wednesday, August 13, 2014, at 1:20 p.m. ET.
Sign-up for Oxygen Biotherapeutics to Present at Wedbush 2014 Life Sciences Management Access Conference investment picks
2014/8/7
Net revenues of $126.3 million and net income of $2.1 million, or $0.17 per diluted share, for the three months ended June 30, 2014, compared to net revenues of $123.6 million and net income of $5.3 million, or $0.43 per diluted share, for the same period of fiscal 2013.
Sign-up for Haynes International, Inc. Reports Third Quarter Fiscal 2014 Financial Results investment picks
DELIVERS $175M IN BOOKINGS AND $14M IN ADJUSTED EBITDA SAN FRANCISCO, Aug.
Sign-up for Zynga Announces Second Quarter 2014 Financial Results investment picks
2014/8/7
End of quarter cash, cash equivalents and short-term investments balance of $90.2 million.
Sign-up for Amyris Reports Second Quarter 2014 Financial Results investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0961629001&sourceType=1 http://media3.marketwire.com/logos/20121108-TSLLOGFUL.jpg VANCOUVER, BRITISH COLUMBIA --
Sign-up for Tree Island Steel Announces Second Quarter 2014 Results investment picks
~ Achieves Record Revenue and Earnings ~ SAN JOSE, Calif., Aug.
Sign-up for Ubiquiti Networks Reports Record Fourth Quarter Fiscal 2014 Financial Results investment picks
2014/8/7
Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, announced today financial results for the three-month period ended June 30, 2014.
Sign-up for Spectrum Pharmaceuticals Reports 45% Sales Growth in the Second Quarter, Launches Fifth Product and Moves Closer to a Decision on a Potential Blockbuster investment picks
Gap Inc. (NYSE: GPS) today reported that July net sales for the four-week period ended August 2, 2014 increased 5 percent to $1.17 billion compared with net sales of $1.12 billion for the four-week period ended August 3, 2013.
Sign-up for Gap Inc. Reports July and Second Quarter Sales Results investment picks
Columbia Property Trust, Inc. (the “Company”) (NYSE: CXP) reported financial results today for the second quarter ended June 30, 2014.
Sign-up for Columbia Property Trust Reports Second Quarter 2014 Results investment picks
The Board of Directors of Bemis Company, Inc. (NYSE:BMS) announced today that William F.
Sign-up for Bemis Company Announces Leadership Transition investment picks
The Board of Directors of Bemis Company, Inc. (NYSE:BMS) has declared a regular quarterly dividend of 27 cents per share.
Sign-up for Bemis Company Declares Regular Quarterly Dividend investment picks
NEWARK, Del., Aug.
Sign-up for Artesian Resources Corporation Reports Second Quarter 2014 Results investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0961637001&sourceType=1 TORONTO, ONTARIO --
Sign-up for Merus Labs International Inc. Subsidiary Signs Product Acquisition Letter of Intent investment picks
Rentech Nitrogen Partners, L.P. (NYSE: RNF) today announced selected financial results for the three and six months ended June 30, 2014.
Sign-up for Rentech Nitrogen Partners, L.P. Announces Selected Results and Cash Distribution for Second Quarter 2014 investment picks
Rentech, Inc. (NASDAQ: RTK) today announced selected financial results for the three and six months ended June 30, 2014.
Sign-up for Rentech Announces Selected Results for Second Quarter 2014 investment picks
Alnylam Pharmaceuticals, Inc .
Sign-up for Alnylam Pharmaceuticals Reports Second Quarter 2014 Financial Results and Highlights Recent Period Activities investment picks
Ignite Restaurant Group (NASDAQ:IRG) today reported financial results for the second quarter ended June 30, 2014.
Sign-up for Ignite Restaurant Group Reports Second Quarter 2014 Financial Results investment picks
NIC Inc. (NASDAQ: EGOV), the dominant provider of official eGovernment services, today announced net income of $11.0 million and earnings per share of 17 cents on total revenues of $71.2 million for the three months ended June 30, 2014.
Sign-up for NIC Earns 17 Cents Per Share in Second Quarter 2014; Same-State Revenues and Contribution from New State Portals Drive 26 Percent Operating Margin investment picks
Clovis Oncology , Inc. (NASDAQ:CLVS) reported financial results for its second quarter ended June 30, 2014, and provided an update on the Company’s clinical development programs for the rest of 2014.
Sign-up for Clovis Oncology Announces Second Quarter 2014 Operating Results investment picks
Knight Transportation, Inc. (NYSE: KNX) announced today that its Board of Directors has declared the company’s quarterly cash dividend of $0.06 per share of common stock.
Sign-up for Knight Transportation Announces Quarterly Cash Dividend investment picks
2014/8/7
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0961639001&sourceType=1 KING CITY, ONTARIO --
Sign-up for TWC Enterprises Limited Announces Second Quarter 2014 Results and Eligible Dividend investment picks
GAITHERSBURG, Md., Aug.
Sign-up for Novavax to Present at the Wedbush Securities Life Sciences Management Access Conference investment picks
2014/8/7
Polaris Industries Inc. inducted three retired employees, including two executives, three premier dealerships, and a key supplier into the Polaris Hall of Fame.
Sign-up for Polaris Industries Honors New Hall of Fame Inductees as Company Celebrates Its 60th Anniversary Year investment picks
OPKO Health, Inc. (NYSE: OPK), announced the submission of an Investigational New Drug (IND) Application to the United States (U.S.) Food and Drug Administration (FDA) under which Rayaldee ™ will begin clinical evaluation as an adjunctive therapy for the prevention of skeletal-related events (SREs) in patients with bone metastases undergoing anti-resorptive therapy.
Sign-up for OPKO Submits IND for Rayaldee™ as Adjunctive Cancer Therapy investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Amicus Therapeutics Announces Second Quarter 2014 Financial Results and Corporate Updates to OPKO Submits IND for Rayaldee™ as Adjunctive Cancer Therapy
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices